The model would adjust Medicare payment for Part B physician-administered drugs based on the lowest prices of that drug in other countries.
The original model was set to roll out at the start of 2021, but was blocked by a U.S. District Court.
CMS received over 1,100 comments on the model, with many agreeing about its mission to combat prescription drug pricing but also expressing concerns over a Jan. 1, 2021, rollout date, according to the document.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
